fluconazole has been researched along with Heart Failure in 9 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Amphotericin B was the only other antifungal that demonstrated a 2D SDR with CHF-related events." | 1.39 | A quantitative analysis of the spontaneous reporting of congestive heart failure-related adverse events with systemic anti-fungal drugs. ( Hauben, M; Hung, EY, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Broderick, KL | 1 |
| Peters, CJ | 1 |
| Mazurek, JA | 1 |
| Wald, J | 1 |
| Zhang, RS | 1 |
| Atluri, P | 1 |
| Urgo, K | 1 |
| Goldberg, L | 1 |
| Blumberg, EA | 1 |
| Weikert, BC | 1 |
| Birati, EY | 1 |
| Allen, L | 1 |
| Bartash, R | 1 |
| Minamoto, GY | 1 |
| Cowman, K | 1 |
| Patel, S | 1 |
| Vukelic, S | 1 |
| Nnani, DU | 1 |
| Fauvel, D | 1 |
| Guo, Y | 1 |
| Yazdanpanah, S | 2 |
| Ahmadi, M | 2 |
| Zare, Z | 2 |
| Nikoupour, H | 2 |
| Arabsheybani, S | 2 |
| Jabrodini, A | 2 |
| Eghtedarnejad, E | 2 |
| Chamanpara, P | 2 |
| Geramizadeh, B | 2 |
| Anbardar, MH | 2 |
| Malekizadeh, Z | 2 |
| Gashtasebi, M | 2 |
| Mohsenzadeh, M | 2 |
| Shafiekhani, M | 2 |
| Zomorodian, K | 2 |
| Siciliano, RF | 1 |
| Gualandro, DM | 1 |
| Sejas, ONE | 1 |
| Ignoto, BG | 1 |
| Caramelli, B | 1 |
| Mansur, AJ | 1 |
| Sampaio, RO | 1 |
| Pierrotti, LC | 1 |
| Barbosa, G | 1 |
| Golebiovski, W | 1 |
| Weksler, C | 1 |
| Lamas, C | 1 |
| Fortes, NRQ | 1 |
| Fortes, CQ | 1 |
| Tarasoutchi, F | 1 |
| Strabelli, TMV | 1 |
| Hauben, M | 1 |
| Hung, EY | 1 |
| Maly, J | 1 |
| Szarszoi, O | 1 |
| Netuka, I | 1 |
| Dorazilova, Z | 1 |
| Pirk, J | 1 |
| Gamma, R | 1 |
| Carrel, T | 1 |
| Schmidli, J | 1 |
| Zimmerli, S | 1 |
| Tanner, H | 1 |
| Hullin, R | 1 |
| Mohacsi, PJ | 1 |
| du Plessis, FA | 1 |
| Helbing, WA | 1 |
| Bogers, AJ | 1 |
| Saito, Y | 1 |
| Takahashi, M | 1 |
| Sato, A | 1 |
| Katsuki, T | 1 |
| Ikeda, U | 1 |
| Shimada, K | 1 |
1 review available for fluconazole and Heart Failure
| Article | Year |
|---|---|
Fungal infections associated with long-term mechanical circulatory support-diagnosis and management.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Fluconazole; Heart Failure; Heart-Assist Devices; Hum | 2014 |
8 other studies available for fluconazole and Heart Failure
| Article | Year |
|---|---|
Characteristics and Outcomes of Candidemia in Patients with Durable Left Ventricular Assist Device Support.
Topics: Candidemia; Diabetes Mellitus; Fluconazole; Heart Failure; Heart-Assist Devices; Humans; Retrospecti | 2022 |
Impact of narrowing perioperative antibiotic prophylaxis for left ventricular assist device implantation.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefazolin; Ciprofloxacin; Fluconazole; Heart Failure; | 2022 |
Assessment of Risk Factors and Clinical Outcomes in Hospitalized COVID-19 Patients with Candida spp. Co-infections: Species Distribution and Antifungal Susceptibility Patterns of Isolates.
Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis; Coinfection; COVID-19; Drug Resistance, F | 2023 |
Assessment of Risk Factors and Clinical Outcomes in Hospitalized COVID-19 Patients with Candida spp. Co-infections: Species Distribution and Antifungal Susceptibility Patterns of Isolates.
Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis; Coinfection; COVID-19; Drug Resistance, F | 2023 |
Assessment of Risk Factors and Clinical Outcomes in Hospitalized COVID-19 Patients with Candida spp. Co-infections: Species Distribution and Antifungal Susceptibility Patterns of Isolates.
Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis; Coinfection; COVID-19; Drug Resistance, F | 2023 |
Assessment of Risk Factors and Clinical Outcomes in Hospitalized COVID-19 Patients with Candida spp. Co-infections: Species Distribution and Antifungal Susceptibility Patterns of Isolates.
Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis; Coinfection; COVID-19; Drug Resistance, F | 2023 |
Outcomes in patients with fungal endocarditis: A multicenter observational cohort study.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Echinocandins; Endocarditis; Female; Fluconazole; | 2018 |
A quantitative analysis of the spontaneous reporting of congestive heart failure-related adverse events with systemic anti-fungal drugs.
Topics: Adverse Drug Reaction Reporting Systems; Amphotericin B; Antifungal Agents; Databases, Factual; Drug | 2013 |
Transplantation of yeast-infected cardiac allografts: a report of 2 cases.
Topics: Adult; Amphotericin B; Candida albicans; Candidiasis; Fluconazole; Follow-Up Studies; Graft Survival | 2005 |
Excision of the tricuspid valve in a baby with Candida endocarditis.
Topics: Antifungal Agents; Candidiasis; Endocarditis; Female; Fluconazole; Heart Failure; Humans; Infant; Ni | 2007 |
Isolated tricuspid valve endocarditis due to Candida parapsilosis associated with long-term central venous catheter implantation.
Topics: Aged; Amphotericin B; Antifungal Agents; Candidiasis; Catheterization, Central Venous; Echocardiogra | 2001 |